S&P 500 7,585.73 −0.45%
Nasdaq 25,981.57 −0.78%
S&P/TSX 35,582.07 −0.34%
Apple 331.34 −0.52%
Nvidia 212.17 +0.57%
Microsoft 497.12 −1.64%
Shopify 180.80 −2.89%
Royal Bank 284.21 −0.34%
CAD/USD 0.7178 −0.23%
CLOSED · 00:10 ET
Market ClerkRecap
Wed Sep 16 · markets closed4 signals on Sep 15287 insider buys this week · $349.4MCIRO short report next: Sep 29The week ahead
MK
INSIDER · INBX · Inhibrx Biosciences, Inc. · DIRECTOR

MANHARD KIMBERLY

Every open-market transaction filed under this name, Sep 8 to Sep 15.

Filings
5
0 buys · 5 sells
Bought
open market, at cost
Sold
$279K
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 15INBXInhibrx Biosciences, Inc.DirectorSell500$105.05$53K+5.2%
Sep 14INBXInhibrx Biosciences, Inc.DirectorSell500$110.26$55K+0.2%
Sep 11INBXInhibrx Biosciences, Inc.DirectorSell500$111.78$56K−1.2%
Sep 9INBXInhibrx Biosciences, Inc.DirectorSell500$115.80$58K−4.6%
Sep 8INBXInhibrx Biosciences, Inc.DirectorSell500$115.14$58K−4.1%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.